The University Of Alabama At Birmingham — Birmingham, Alabama

The University Of Alabama At Birmingham is a clinical research site located in Birmingham, Alabama, United States 35233.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

The University Of Alabama At Birmingham has participated in 4 clinical trials.

Therapeutic areas: Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease.

Sponsors: Bristol-Myers Squibb, Pfizer, Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University Of Alabama At Birmingham?

The University Of Alabama At Birmingham has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University Of Alabama At Birmingham conducted?

The University Of Alabama At Birmingham has 4 clinical trials on record. Their work covers Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease.

Is The University Of Alabama At Birmingham accredited by Crixeo Health?

Yes — The University Of Alabama At Birmingham holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The University Of Alabama At Birmingham?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.